We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$598M
AUM Growth
+$76.5M
Cap. Flow
+$64.6M
Cap. Flow %
10.8%
Top 10 Hldgs %
39.45%
Holding
336
New
90
Increased
41
Reduced
12
Closed
71

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Healthcare 18.49%
3 Financials 10.5%
4 Industrials 9.85%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSPC
301
DELISTED
Post Holdings Partnering Corporation
PSPC
-463,600
Closed -$4.69M
AQUA
302
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-110,309
Closed -$5.48M
AXAC.RT
303
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Rights to receive one-tenth (1/10) of one Class A ordinary share
AXAC.RT
-173,500
Closed -$33K
AXAC.WS
304
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AXAC.WS
-173,500
Closed -$6.07K
GBRGR
305
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
-47,400
Closed -$21.5K
TA
306
DELISTED
TravelCenters of America LLC
TA
-186,500
Closed -$16.1M
TBMCU
307
DELISTED
Trailblazer Merger Corporation I Unit
TBMCU
-56,100
Closed -$566K
SUMO
308
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-358,150
Closed -$4.29M
PGRWW
309
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
-32,150
Closed -$1.77K
JNCE
310
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-425,100
Closed -$786K
MAXR
311
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-298,200
Closed -$15.2M
OSH
312
DELISTED
Oak Street Health, Inc.
OSH
-669,200
Closed -$25.9M
TRAQ.WS
313
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
-108,439
Closed -$5.42K
TRAQ
314
DELISTED
Trine II Acquisition Corp.
TRAQ
-216,878
Closed -$2.27M
CIIG
315
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
-87,700
Closed -$912K
CIIGW
316
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
-43,850
Closed -$5.48K
PRVB
317
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-148,400
Closed -$3.58M
CSII
318
DELISTED
Cardiovascular Systems, Inc.
CSII
-290,850
Closed -$5.78M
BMAQ
319
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
-66,526
Closed -$705K
BMAQR
320
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
-66,526
Closed -$3.49K
BMAQW
321
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
-66,526
Closed -$1.25K
TIG
322
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
-178,750
Closed -$1.09M
ATCX
323
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
-83,750
Closed -$1.02M
KALWW
324
DELISTED
Kalera Public Limited Company Warrant
KALWW
-27,000
Closed -$726
BSGAR
325
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
-85,030
Closed -$45.9K

Similar funds

Gabelli & Co Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, Gabelli & Co Investment Advisers held 336 positions worth $598M, up 15% from $521M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Gabelli & Co Investment Advisers deployed $64.6M of net new capital in Q2 2023, opening 90 new positions and adding to 41 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rogers Corp, an estimated $11.3M trimmed.

  • Gabelli & Co Investment Advisers's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.
  • Gabelli & Co Investment Advisers added most to National Instruments Corp in Q2 2023, an estimated $17.7M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2023 reduction was Rogers Corp, cutting an estimated $11.3M.
  • Gabelli & Co Investment Advisers fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $25.9M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 39% of its $598M portfolio in Q2 2023.
  • Gabelli & Co Investment Advisers opened 90 new positions and closed 71 in Q2 2023.
  • Gabelli & Co Investment Advisers's portfolio value rose 15% quarter-over-quarter to $598M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.